cadmium has been researched along with B16 Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garvey, J; Kraker, AJ; Pattanaik, A; Petering, DH; Shaw, CF | 1 |
| Graham, CH; Khokha, R; Lala, PK; Waterhouse, P; Zimmer, MJ | 1 |
| Koropatnick, J; Pearson, J | 1 |
3 other study(ies) available for cadmium and B16 Melanoma
| Article | Year |
|---|---|
Basal metallothionein in tumors: widespread presence of apoprotein.
Topics: Animals; Apoproteins; Binding, Competitive; Cadmium; Chromatography, Gel; Chromatography, High Pressure Liquid; Humans; Male; Mammary Neoplasms, Experimental; Melanoma, Experimental; Metallothionein; Mice; Neoplasms, Experimental; Radioimmunoassay; Rats; Rhabdomyosarcoma; Sarcoma, Experimental; Splenic Neoplasms; Zinc | 1994 |
Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells.
Topics: Animals; Cadmium; Gene Expression Regulation, Neoplastic; Glycoproteins; Melanoma, Experimental; Mice; Microbial Collagenase; Neoplasm Invasiveness; RNA, Messenger; Tissue Inhibitor of Metalloproteinases; Tumor Cells, Cultured; Up-Regulation | 1992 |
Zinc treatment, metallothionein expression, and resistance to cisplatin in mouse melanoma cells.
Topics: Animals; Cadmium; Cell Line; Cell Survival; Cisplatin; Drug Resistance; Gene Expression; Melanoma, Experimental; Metallothionein; Methotrexate; Mice; RNA, Messenger; Zinc | 1990 |